Abstract
Three cell lines of small cell lung cancer (SCLC), which were established from specimens of untreated primary tumors biopsied by diagnostic bronchofiberscopy, were analyzed for immunological characteristics. These cell lines showed considerable heterogeneity in chemo‐radiosensitivity, which was well correlated with clinical responses of the respective tumors, but their HLA‐class I antigen expressions were equally depressed and they were susceptible to peripheral blood lymphocytes (PBL) and lymphokine‐activated killer (LAK) cells, irrespective of their diverse chemo‐radiosensitivity. Treatment of the cell lines with recombinant immune interferon (rIFN‐γ) increased their HLA‐class I antigen expression and conversely depressed PBL sensitivity but not LAK sensitivity. This inverse relationship between HLA‐class I expression and PBL susceptibility was also demonstrated using other pairs of autologous PBL and SCLC cell lines. rIFN‐γ changed neither HLA‐class H antigen nor SCLC‐spccilic antigen expression under the same experimental conditions. In vitro immunization of allogeneic peripheral blood lymphocytes with rIFN‐γ ‐treated SCLC cells induced allo‐specific killer cells which lysed rIFN‐7‐treated more strongly than non‐treated SCLC cells. These results suggest that reduced HLA‐class I antigen expression of SCLC could protect the cancer from attack of killer T cells in spite of the higher sensitivity to PBL or LAK cells.
Keywords: Key words, Small cell lung cancer, Chemo‐radiosensitivity, Peripheral blood lymphocyte, HLA‐class I, Interferon‐γ
Full Text
The Full Text of this article is available as a PDF (617.3 KB).
REFERENCES
- 1. ) Doyle , A. , Martin , W. J. , Funa , K. , Gazdar , A. , Carney , D. , Martin , S. L. , Linnoila , I. , Cuttitta , F. , Mulshine , J. , Bunn , P. and Minna , J.Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small‐cell lung cancer . J. Exp. Med. , 161 , 1135 – 1151 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Faltynek , C. R. and Oppenheim , J. J.Interferons in host defense . J. Natl. Cancer Inst. , 80 , 151 – 153 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Hokland , M. , Basse , P. , Justesen , J. and Hokland , P.IFN‐induced modulation of histocompatibility antigens on human cells . Cancer Metastasis Rev. , 7 , 193 – 207 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Guadagni , F. , Schlom , J. , Johnston , W. W. , Szpak , C. A. , Goldstein , D. , Smalley , R. , Simpson , J. F. , Borden , E. C. , Pestka , S. and Greiner , J. W.Selective interferon‐induced enhancement of tumor‐associated antigens on a spectrum of freshly isolated human adenocarcinoma cells . J. Natl. Cancer Inst. , 81 , 502 – 512 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Jaffe , H. S. and Herberman , R. B.Rationale for recombinant human interferon‐gamma adjuvant immunotherapy for cancer . J. Natl. Cancer Inst. , 80 , 616 – 618 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Fergusson , R. J. and Smyth , J. F.Interferons and lung cancer: preclinical and clinical investigations . In “ Basic and Clinical Concepts of Lung Cancer ,” ed. Hansen H. H. , pp. 173 – 182 ( 1989. ). Kluwer Academic Publishers; , Boston . [DOI] [PubMed] [Google Scholar]
- 7. ) Ljunggren , H. G. and Karre , K.In search of the missing self: MHC molecules and NK cell recognition . Immunol. Today , 11 , 237 – 244 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Hercend , T. and Schmidt , R. E.Characteristics and uses of natural killer cells . Immunol. Today , 9 , 291 – 293 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Trinchieri , G.Biology of natural killer cells . Adv. Immunol. , 47 , 187 – 376 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Tanio , Y. , Watanabe , M. , Inoue , T. , Kawase , I. , Shirasaka , T. , Ikeda , T. , Hara , H. , Masuno , T. , Saito , S. , Kawano , K. , Kitamura , H. , Kubota , K. , Kodama , N. , Kawahara , M. , Sakatani , M. , Furuse , K. , Yamamoto , S. and Kishimoto , S.Chemo‐radioresistance of small cell lung cancer cell lines derived from untreated primary tumors obtained by diagnostic bronchofiberscopy . Jpn. J. Cancer Res. , 81 , 289 – 297 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Saito , S. , Inoue , T. , Kawase , I. , Hara , H. , Tanio , Y. , Tachibana , I. , Hayashi , S. , Watanabe , M. , Matsunashi , M. , Osaki , T. , Masuno , T. and Kishimoto , S.Two monoclonal antibodies against small‐cell lung cancer show existence of synergism in binding . Cancer Immunol. Immunother. , 33 , 165 – 170 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. ) Watanabe , S. , Tsugane , S. , Arimoto , H. , Shimosato , Y. , Suemasu , K. , Arai , H. and Urano , Y.Trend of lung cancers in the National Cancer Center of Japan and comparison with that of Japanese pathological autopsy records . Jpn. J. Cancer Res. , 78 , 460 – 466 ( 1987. ). [PubMed] [Google Scholar]
- 13. ) Tanaka , I. , Matsubara , O. , Kasuga , T. , Takemura , T. and Inoue , M.Increasing incidence and changing histopathology of primary lung cancer in Japan. A review of 282 autopsied cases . Cancer , 62 , 1035 – 1039 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Harker , W. G. , Tom , C. , McGregor , J. R. , Slade , L. and Samlowski , W. E.Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine‐activated killer cell‐mediated cytolysis . Cancer Res. , 50 , 5931 – 5936 ( 1990. ). [PubMed] [Google Scholar]
- 15. ) Powell , J. , Stone , J. , Chan , W. C. , Yang , Z.‐D. , Leatherbury , A. , Sell , K. W. , Wiktor‐Jedrzejczak , W. and Ahmed‐Ansari , A.Interferon‐r‐treated K562 target cells distinguish functional NK cells from lymphokine‐activated killer (LAK) cells . Cell. Immunol. , 118 , 250 – 264 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 16. ) De Fries , R. U. and Golub , S. H.Characteristics and mechanism of IFN‐7‐induced protection of human tumor cells from lysis by lymphokine‐activated killer cells . J. Immunol. , 140 , 3686 – 3693 ( 1988. ). [PubMed] [Google Scholar]
- 17. ) Lagadec , P. F. , Saraya , K. A. and Balkwill , F. R.Human small‐cell lung‐cancer cells are cytokine‐resistant but NK/LAK‐sensitive . Int. J. Cancer , 48 , 311 – 317 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Stam , N. J. , Kast , W. M. , Voordouw , A. C. , Pastoors , L. B. , van der Hoeven , F. A. , Melief , C. J. M. and Ploegh , H. L.Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells . J. Immunol. , 142 , 4113 – 4117 ( 1989. ). [PubMed] [Google Scholar]
- 19. ) Storkus , W. J. , Alexander , J. , Payne , J. A. , Cresswell , P. and Dawson , J. R.The α1/α2 domains of class I HLA molecules confer resistance to natural killing . J. Immunol , 143 , 3853 – 3857 ( 1989. ). [PubMed] [Google Scholar]
- 20. ) Liao , N.‐S. , Bix , M. , Zijlstra , M. , Jaenisch , R. and Raulet , D.MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity . Science , 253 , 199 – 202 ( 1991. ). [DOI] [PubMed] [Google Scholar]